MedTrace Logo

Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation

NCT00631813 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 253

Last updated 2008-05-29

No results posted yet for this study

Summary

The purpose of this study is to determine which dose of prucalopride is safe and effective in patients with chronic constipation.

Hypothesis:

Prucalopride 1 and 2 mg bid are safe and effective for the treatment of chronic constipation whereas 0,5 mg is a suboptimal dose.

Conditions

Interventions

DRUG

Prucalopride

0.5 mg bid

DRUG

Prucalopride

1 mg bid

DRUG

Prucalopride

2 mg bid

DRUG

Placebo

bid

Sponsors & Collaborators

  • Movetis

    lead INDUSTRY

Principal Investigators

  • P. Van Eeghem, MD · Onze Lieve Vrouw Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-11-30
Primary Completion
1997-04-30
Completion
1997-04-30

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00631813 on ClinicalTrials.gov